Evidence map›Paper›PMID 36759195›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2023

Epilepsy-Related CDKL5 Deficiency Slows Synaptic Vesicle Endocytosis in Central Nerve Terminals.

Christiana Kontaxi, Daniela Ivanova, Elizabeth C Davenport, Peter C Kind, Michael A Cousin

Open access · greenAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biogenesis and reformation of synaptic vesicles.The Journal of physiology · 2025
    Review
  5. Article
  6. Transcriptomic Profiling of Zebrafish Mutant forInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease.Journal of cellular and molecular medicine · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christiana KontaxiCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom.
Daniela IvanovaCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom.
Elizabeth C DavenportCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom.
Peter C KindCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom.
Michael A CousinCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom m.cousin@ed.ac.uk.ORCID 0000-0002-1762-160X
Maxwell Institute for Mathematical Sciences · GB

Funding

Wellcome Trust 204954/Z/16/Z
6 · The paper itself

Abstract

Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a severe early-onset epileptic encephalopathy resulting mainly from

Indexed as

Spasms, InfantileSynaptic VesiclesAnimalsCyclin-Dependent KinasesEndocytosisEpileptic SyndromesMaleProtein Serine-Threonine KinasesRatsCDKL5 protein, ratCyclin-Dependent KinasesProtein Serine-Threonine Kinasesendocytosisepilepsyratsynapsevesicle

Identifiers

PMID36759195
PMCPMC10027047
OpenAlexW4319662990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.